15hon MSN
Ozempic-Style Drugs Have Taken the World By Storm. Soon, They May Not Even Require a Needle.
In a 71-week, double-blind study, Nova Nordisk—creators of the popular weight loss drug Wegovy—says their oral semaglutide ...
India Today on MSN
India's obesity drug uptake so far just the 'tip of the iceberg', says Novo Nordisk MD
A 2023 survey by the Indian Council of Medical Research (ICMR) and the Madras Diabetes Research Foundation (MDRF) found that 28.6 percent of Indians — about 25.4 crore people — are affected by ...
Everyday Health on MSN
Retatrutide Is a New GLP-1 Hit. But Is It Legal?
Retatrutide is a powerful experimental weight loss drug that currently lacks FDA approval. Learn how it works, plus the legal and safety risks of buying retatrutide online.
A UC San Diego study reveals GLP-1 receptor agonists, like Ozempic, may significantly reduce colon cancer death rates. Patients using these diabetes a ...
So, what’s really moving the needle on MedTech deals in 2025? It’s a mix of money matters and the rulebook. Think of it like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback